<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Baxter International Inc $ 87.99 0.14 (0.16%)

Volume:
1,832,934
Avg Vol (1m):
2,337,968
Market Cap $:
44.92 Bil
Enterprise Value $:
47.67 Bil
P/E (TTM):
29.53
P/B:
5.78
Warning! GuruFocus has detected 4 Medium warning signs with BAX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

BAX News and Headlines - Baxter International

GuruFocus Articles Total 207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11

Micron Technology makes the list

According to the GuruFocus All-in-One Screener as of Oct. 9, while most of the following companies are trading at a discount, all have positive three- to five-year future earnings estimates.

Shares of CSX Corp. (CSX) were trading around $66 per share on Wednesday.

2e8e6cbba8632ebfcaaa2abb01f5b973.png

The American railroad operator has a GuruFocus profitability and growth rating of 8 out of 10. Its earnings per share have risen 22.20% over the last five years. Analysts project a three-year to five-year earnings growth rate of 9.68%. The return on equity of 26.46% and return on assets

410 Views    Tiziano Frateschi    2019-10-09 18:42
Investment company Cerebellum GP, LLC (Current Portfolio) buys Idacorp Inc, Bank of Montreal, Ameren Corp, Apple Inc, Fidelity National Information Services Inc, sells Ball Corp, Cummins Inc, HollyFrontier Corp, KeyCorp, Valero Energy Corp during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Cerebellum GP, LLC. As of 2019Q3, Cerebellum GP, LLC owns 417 stocks with a total value of $155 million. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-09 17:38
Companies recognized by key industry publication for innovative approaches

Investors may want to put on their radar screen the 15 private and independent biotech companies recognized by FierceBiotech for their novel methods to conquer a variety of diseases.

The companies can be evaluated as potential investments in a number of ways: their technology, therapeutic areas of concentration, the experience and track record of leadership and the size and reputation of their backers.

“Small, gutsy biotechs are still attracting venture capitalists, the public markets and Big Pharma suitors,” Ben Adams wrote in the Sept. 23 article listing the top 15.

Among the young companies, there may be a few

144 Views    Barry Cohen    2019-09-23 22:17
Activist guru’s top holdings include Baxter and United Technologies

According to current portfolio statistics, Daniel Loeb (Trades, Portfolio)’s top-five holdings as of the second quarter were Baxter International Inc. (BAX), United Technologies Inc. (UTX), Campbell Soup Co. (CPB), Danaher Corp. (DHR) and PayPal Holdings Inc. (PYPL).

Loeb, who founded New York-based Third Point in 1995, leads the firm’s research activities, portfolio and risk management. The firm focuses on a value-oriented, activist investing approach: Loeb seeks investments where a catalyst has potential to increase shareholder value.

The fund manager said in his shareholder letter that the firm returned 13.1% through the first

410 Views    James Li    2019-09-09 21:00
Guru's largest sales of the 2nd quarter

Bill Nygren (Trades, Portfolio), manager of the Oakmark Fund, sold shares of the following stocks in the second quarter.

The guru closed his Anadarko Petroleum Corp. (APC) position when it was acquired by Occidental Petroleum (OXY). The portfolio was impacted by -1.69%.

075b0ec43eb65bff848127503b38b5b4.png

On its last trading day, the oil and gas producer had a market cap of $36.56 billion and an enterprise value of $55.51 billion.

The DXC Technology Co. (DXC) holding was closed. The portfolio was impacted by -1.47%.

47a9a3a2dc1caf461d25b5c8610864c7.png

The company, which provides IT

101 Views    Tiziano Frateschi    2019-08-26 19:05
Capital One makes the list

According to the GuruFocus All-in-One Screener, the following companies, as of Thursday, look cheap since they are trading with low price-sales ratios.

Shares of Baxter International Inc. (BAX) are trading around $86 with a price-sales ratio of 4.17 and a price-earnings ratio of 28.91.

The medical products manufacturer has a market cap of $42.87 billion. The stock has risen at an annualized rate of 12.40% over the last 10 years.

670fdce1a3447a0ee7e2fb8fd7234bdc.png

The discounted cash flow calculator gives the stock a fair value of $31.89, suggesting it is overpriced by 170%. The Peter Lynch earnings

117 Views    Tiziano Frateschi    2019-08-01 18:47
Top buys include 2 companies guru exited during 4th-quarter 2018

Daniel Loeb (Trades, Portfolio), founder of hedge fund Third Point, disclosed this week that his top buys for the first quarter included several companies the firm sold out of during the prior quarter, including United Technologies Inc. (UTX) and Marathon Petroleum Corp. (MPC).

Loeb said in his shareholder letter that the Third Point Offshore Fund gained 8.8% during the quarter, driven by strong activist and constructivist positions including Nestle SA (XSWX:NESN), Baxter International Inc. (BAX), United Technologies and Campbell Soup Co. (CPB).

89d4a040-78c2-11e9-853d-ff257878620b.png

Guru reasserts activist approach to investing

Loeb said in

1852 Views    James Li    2019-05-17 21:24
In his 1st-quarter letter, the guru explains what he looks for in management's long-term incentive plans

Daniel Loeb (Trades, Portfolio) of Third Point focuses on activist investing. The firm employs an event-driven, value investment style. The Offshore Fund just published its first-quarter report. It gained 8.8%, driven primarily by activist positions Nestlé (XSWX:NESN), Baxter International (BAX), United Technologies (UTX) and Campbell Soup (CPB).

Third Point also had hedges and shorts in place that held back its performance. This letter was extremely interesting because Loeb talked about some research the firm is doing into long-term executive compensation with some

109 Views    Bram de Haas    2019-04-28 01:32
Baxter International makes the list

According to the GuruFocus All-in-One Screener, the following companies are trading at a discount and have positive three- to five-year future earnings estimates.

Shares of China Telecom Corp. Ltd. (CHA) are trading around $52 per share. The discounted cash flow calculator gives the stock a fair value of $102.97 per share, suggesting it is undervalued with a 49% margin of safety.

1241750505.png

The Chinese fixed-line operator has a GuruFocus profitability and growth rating of 6 out of 10. Its earnings per share have grown 0.10% over the last five years. Analysts project a three-year

63 Views    Tiziano Frateschi    2019-04-23 21:43

Four New Directors to Be Immediately Appointed to the Board of Directors

Commitment to Adjusted Operating Margin Targets for Q4 2019 and Q4 2020 of 20% and 22.5%, Respectively1

Creation of Finance and Strategy Committee of the Board to Oversee Operational Improvement Initiatives

Increases Share Repurchase Authorization Resulting in $1.5 Billion Available for Repurchase

KANSAS CITY, Mo., April 09, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation ( CERN) (“Cerner” or the “Company”) today announced that the Company has entered into a cooperation

0 Views    Marketwired    2019-04-09 12:00
Largest buy is major Daniel Loeb holding Baxter

The MS Global Franchise Fund (Trades, Portfolio), part of Morgan Stanley (MS), disclosed this week its top five buys for fourth-quarter 2018 were Baxter International Inc. (BAX), Heineken NV (XAMS:HEIA), Reckitt Benckiser Group PLC (LSE:RB), SAP SE (XTER:SAP) and Microsoft Corp. (MSFT).

The fund seeks long-term capital appreciation through investments in securities with resilient business franchises and growth potential. Key characteristics include sustainable return on invested capital, high gross margins, strong free cash flow generation and good financial strength. As of quarter-end, the 31-stock equity portfolio’s top sectors in terms of weight are consumer

250 Views    James Li    2019-03-21 21:13
Guru adds biotech company to health care holdings

Expanding his position in the health care space, billionaire investor Steven Cohen (Trades, Portfolio), who leads Point72 Asset Management, disclosed a 7.3% stake in Aptevo Therapeutics Inc. (APVO) on March 11.

In order to generate superior risk-adjusted returns, the guru’s Connecticut-based hedge fund uses long, short, macro and systematic strategies.

According to a Schedule 13G filing with the Securities and Exchange Commission, Cohen invested in 3.2 million shares of the Seattle-based biotechnology company.

The company, which develops novel oncology, autoimmune and hematology therapeutics, has a $20.14 million market cap; its shares were trading around 88 cents

349 Views    Sydnee Gatewood    2019-03-14 16:13
Anika Therapeutics tops the list

Companies that are growing their earnings are often good investments because they can return a solid profit to investors. According to the discounted cash flow calculator, the following undervalued companies have grown their earnings per share over a five-year period.

The earnings per share of Anika Therapeutics Inc. (ANIK) have grown 10% annually over the last five years.

1629342377.png

According to the DCF calculator, the stock is undervalued and is trading with a 16% margin of safety at $30 per share. The price-earnings ratio is 23.95. The share price has been as high as $54.88 and

86 Views    Tiziano Frateschi    2019-03-11 19:34

NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of XPO Logistics, Inc. (:XPO), L3 Technologies Inc. (:LLL), Domino's Pizza Inc (:DPZ), Baxter International Inc. (:BAX), Conduent Inc. (:CNDT), and Xylem Inc. (:XYL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

XPO

0 Views    Marketwired    2019-03-06 13:02
Guru widens holdings in the health care space

Billionaire investor Steven Cohen (Trades, Portfolio), who heads up hedge fund Point72 Asset Management, disclosed he upped his stake in Karyopharm Therapeutics Inc. (KPTI) on Feb. 22.

The guru’s Connecticut-based firm uses long, short, macro and systematic strategies to generate superior risk-adjusted returns.

According to GuruFocus real-time picks, a Premium feature, Cohen boosted his stake in the Newton, Massachusetts-based company by 127.39%, buying 1.96 million shares for an average price of $5.07 per share. He now holds 3.5 million shares. GuruFocus data shows he has lost approximately 28% on the investment since establishing it in the

486 Views    Sydnee Gatewood    2019-03-01 17:36
Guru stock highlight

Baxter (NYSE:BAX) remains the firm’s largest position and Third Point Partner and Head of Equities Munib Islam serves on the Board of Directors. In past quarterly letters, we detailed our initial investment thesis and highlighted the extraordinary transformation that CEO Joe Almeida has overseen at the company since joining at the end of 2015. Baxter has generated more profits than any investment in our history. We have used open windows to maintain the size of the position as it has grown through appreciation, the best reason to have to right-size an investment. Today, we remain enthusiastic about the direction

40 Views    Holly LaFon    2019-02-22 21:11
Discussion of markets and holdings

Review and Outlook

Third Point’s Offshore Fund lost -11.9% during the Fourth Quarter, bringing returns for 2018 to -11.3%. This was the fourth time in 24 years that we sustained a loss of over 1% in a calendar year and our second double digit decline. Although our performance was disappointing, we took the opportunity to learn from our mistakes, reflect on where our competitive advantages lie, adjust our risk management, and generally improve our processes to drive better results.

Excessive exposure to unhedged long cyclical names and a risk arbitrage position in NXPI accounted for much of the year’s negative

212 Views    Holly LaFon    2019-02-22 20:20
Top buys include Third Point manager’s top holding Baxter

Larry Robbins (Trades, Portfolio), founder of Glenview Capital Management, disclosed last week that he increased his bet in new Daniel Loeb (Trades, Portfolio) holding Cigna Corp. (CI) and established three new holdings during fourth-quarter 2018: Baxter Corp. (BAX), Humana Inc. (HUM) and Livent Corp. (LTHM).

Managing a portfolio of 50 stocks, Robbins focuses on delivering attractive returns through an intense focus on fundamental research and individual security selection. According to current portfolio statistics, Robbins’ long equity portfolio contains 53.12% weight in the health care sector.

d2e506f0-3545-11e9-b6b8-290e567741f3.png

Cigna

Robbins

219 Views    James Li    2019-02-20 22:44
Guru's largest sales of 4th quarter

The Third Point LLC's founder Daniel Loeb (Trades, Portfolio) sold shares of the following stocks during the fourth quarter.

The guru closed his United Technologies Corp. (UTX) holding. The trade had an impact of -8.21% on the portfolio.

84009ac0-2dfb-11e9-8610-c3cee633ed52.png

The company, which provides high technology products and services to the aerospace industries, has a market cap of $105.56 billion and an enterprise value of $147.3 billion.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 16.26% and return on assets of

59 Views    Tiziano Frateschi    2019-02-12 17:53

NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ensco plc (:ESV), Third Point Reinsurance Ltd. (:TPRE), Baxter International Inc. (:BAX), Ultrapar Participacoes S.A. (:UGP), Endeavour Silver Corporation (:EXK), and Ingles Markets, Incorporated (IMKTA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2019-02-04 13:03

Headlines Total 620
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

2019-10-18 $ 87.99 (0.16%)
10:21am
2019-10-17 $ 87.85 (0.95%)
9:33am
2019-10-10 $ 87.61 (0.82%)
8:30am
2019-10-08 $ 85.01 (-0.91%)
6:04am
2019-10-02 $ 84.23 (-1.96%)
8:48am
2019-09-27 $ 85.93 (-2.05%)
9:08am
2019-09-24 $ 86.45 (-0.45%)
10:12am
2019-09-23 $ 86.84 (-0.64%)
10:25am
10:18am
10:09am
2019-09-20 $ 87.4 (-0.07%)
10:56am
9:57am
7:45am
2019-09-19 $ 87.46 (0.02%)
9:25am
8:55am
2019-09-18 $ 87.44 (-0.15%)
10:16am
8:59am
8:25am
8:22am
6:57am
2019-09-17 $ 87.57 (0.75%)
10:07am
9:18am
9:00am
8:54am
8:52am
2019-09-16 $ 86.92 (-0.01%)
9:05am
8:47am
7:29am
7:26am
7:09am
2019-09-13 $ 86.93 (-1.01%)
9:54am
8:40am
8:07am
7:16am
2019-09-12 $ 87.82 (1.28%)
10:09am
9:52am
9:10am
8:09am
2019-09-11 $ 86.71 (0.93%)
10:27am
8:04am
2019-09-10 $ 85.91 (-1.48%)
10:33am
10:27am
8:46am
7:07am
7:03am
7:00am
2019-09-09 $ 87.2 (-2.87%)
4:00pm
10:34am
10:27am
8:29am
8:27am
8:21am
8:11am
6:49am
2019-09-06 $ 89.78 (2.13%)
8:55am
8:29am
7:35am
2019-09-05 $ 87.91 (0.47%)
9:16am
6:54am
6:17am
2019-09-04 $ 87.5 (-0.32%)
8:18am
7:32am
2019-09-03 $ 87.78 (-0.19%)
10:04am
9:46am
8:19am
8:16am
7:50am
7:11am
2019-09-02 $ 87.95 (%)
7:40am
7:37am
7:37am
7:21am
7:07am
2019-08-30 $ 87.95 (0.51%)
8:36am
7:36am
2019-08-29 $ 87.5 (0.66%)
8:56am
8:36am
8:02am
7:37am
6:38am
2019-08-28 $ 86.93 (0.63%)
9:14am
8:13am
7:42am
7:14am
2019-08-27 $ 86.39 (0.72%)
10:24am
7:56am
7:54am
2019-08-26 $ 85.77 (0.87%)
12:05pm
9:47am
8:10am
8:08am
8:08am
6:49am
2019-08-24
8:31am
2019-08-23 $ 85.03 (-2.5%)
9:30am
8:12am
6:17am
5:51am
2019-08-22 $ 87.21 (-0.11%)
10:45am
10:40am
Total 620
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7